Similar articles

• [Behavior of serum immunoglobulins during and after intravenous administration of gamma globulin in subjects with antibody deficiency syndromes].

  Gravina E, Gravina-Sanvitale G. Gravina E, et al. Minerva Pediatr. 1975 Jun 9;27(20):1166-70. Minerva Pediatr. 1975. PMID: 49009 Italian. No abstract available.
• Use of intravenous pH 4.0 treated gamma globulin in humoral immunodeficiency disease.

  Cunningham-Rundles C, Smithwick EM, Siegal FP, Day NK, Lion A, O'Malley J, Barandun S, Good RA. Cunningham-Rundles C, et al. Birth Defects Orig Artic Ser. 1983;19(3):201-3. Birth Defects Orig Artic Ser. 1983. PMID: 6197105 Clinical Trial. No abstract available.
• [Intravenous gamma globulin therapy in Bruton's antibody deficiency syndrome].

  Rossipal E. Rossipal E. Wien Med Wochenschr. 1978 Apr 30;128(8):240-3. Wien Med Wochenschr. 1978. PMID: 77587 German. No abstract available.
• [Therapy with immunoglobulins with special regard to the problem of the efficacy of intravenously applied gammaglobulin in bacterial infections].

  Duswald KH, Ring J. Duswald KH, et al. Klin Anasthesiol Intensivther. 1980;21:207-23. Klin Anasthesiol Intensivther. 1980. PMID: 6161270 Review. German. No abstract available.
• Treatment of defects of humoral immunity.

  Eibl M. Eibl M. Birth Defects Orig Artic Ser. 1983;19(3):193-200. Birth Defects Orig Artic Ser. 1983. PMID: 6228269 Review. No abstract available.